-
JP Morgan Downgrades NVO To Neutral
Monday, April 11, 2011 - 6:19am | 43Analysts at JP Morgan downgrade Novo Nordisk A/S (NYSE: NVO) from “overweight” to “neutral.” NVO shares gained 0.77% to close at $128.39 on Friday. More Analyst Ratings here
-
J&J Being Sued By SEC Because Of Foreign Bribery (JNJ)
Friday, April 8, 2011 - 11:59am | 30SEC says Johnson & Johnson (NYSE: JNJ) subsidiaries paid kickbacks to Iraq and doctors in Greece. J&J will pay more than $70M.
-
SEC Sues Johnson & Johnson for Foreign Bribery - Bloomberg
Friday, April 8, 2011 - 11:52am | 27According to Bloomberg, SEC Sues Johnson & Johnson (NYSE: JNJ) for Foreign Bribery. The company to pay more than $70M.
-
Jazz Pharmaceuticals Hits 52-Week High (JAZZ)
Friday, April 8, 2011 - 11:16am | 33Jazz Pharmaceuticals (NASDAQ: JAZZ) has hit a 52-week high in today's trading. At last check the year-to-date performance of Jazz has been a gain of 73%.
-
Could the Nasdaq Re-Weight Be a "Non-Event" for Apple (NASDAQ:AAPL)?
Friday, April 8, 2011 - 9:54am | 2055About 18 months ago – On October 20, 2009, to be specific – I posed the question, “Is it Time to Re-Weight the Nasdaq 100?”* At that time, Apple (NASDAQ:AAPL) shares had a 15.6% weighting in the 100-stock index (and by default, the Nasdaq-100 Trust). At the time, I noted: “…the relative...
-
CORRECTION: Hi-Tech Pharmacal Receives Tentative Approval for Brimonidine Tartrate with Timolol Maleate Ophthalmic Solution
Friday, April 8, 2011 - 9:09am | 110Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that the US Food and Drug Administration, granted tentative approval for the Company's Abbreviated New Drug Application, for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan ophthalmic...
-
Merck Loses U.K. Appeal Against Teva to Reinstate Cosopt Patent (MRK)
Friday, April 8, 2011 - 8:34am | 41Merck (NYSE: MRK) the second-biggest U.S. drug company, lost a U.K. appeal to reinstate its European patent for the glaucoma treatment Cosopt after a successful challenge by Teva Pharmaceutical Industries Ltd.
-
Jefferies Comments On Amarin Corporation Ahead Of Phase 3 Trial
Friday, April 8, 2011 - 8:08am | 167Jefferies view the risk-reward on Amarin Corporation (NASDAQ: AMRN) as favorable going into the expected 2Q data release from the Phase 3 ANCHOR trial in mixed dyslipidemia. Jefferies believe AMR101 may benefit from a cleaner lipid-lowering profile and a potentially broader label than Lovaza, which...
-
Watson Confirms Vigamox Patent Challenge
Friday, April 8, 2011 - 8:00am | 71Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5%. Watson's Moxifloxacin...
-
Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue (HSP, VRX, ELN, KV-A)
Friday, April 8, 2011 - 12:17am | 121Below are the top drug delivery stocks on the NYSE in terms of revenue. The trailing-twelve-month revenue at Hospira Inc (NYSE: HSP) is $3.92 billion. HSP's ROE for the same period is 12.30%. The trailing-twelve-month revenue at Valeant Pharmceutical International Inc (NYSE: VRX) is $1.18 billion...
-
Market Holds Its Ground 04-07-2011
Thursday, April 7, 2011 - 6:54pm | 963Cusick Corner The market braced itself for the news in Japan and has held its ground. But the market is whippy and the fact that it's overbought is looking like it has started to wane, leaving me with uncertainty into the After Hours. I have written over the last few weeks about some strategic...
-
Bullish Stocks to Watch Friday
Thursday, April 7, 2011 - 5:24pm | 1516( click to enlarge ) Rare Element Res Ltd (AMEX:REE) looks strong enough to move forward. As expected, the stock broke up through the resistance at $13.85 on huge volume of over 1.202 Million shares. At this stage, further rally is still possible in next several days. The breakout signals a...
-
U.S. Says Stolen Drugs Were Manufactured By Sanofi-aventis (SNY)
Thursday, April 7, 2011 - 4:40pm | 19U.S. says stolen drugs were manufactured by Sanofi-Aventis (NYSE: SNY).
-
Hi-Tech Pharmacal Receives Tentative Approval for Levofloxacin Oral Solution (HITK)
Thursday, April 7, 2011 - 1:10pm | 138Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced today that the US Food and Drug Administration, granted tentative approval for the Company's Abbreviated New Drug Application, for levofloxacin oral solution 25mg/mL, the generic for McNeil Pharmaceutical's Levaquin® oral solution which had sales...
-
XenoPort Receives FDA Approval For Horizant (XNPT)
Thursday, April 7, 2011 - 1:04pm | 111XenoPort Inc (NASDAQ: XNPT) stock saw a 65% surge in share prices to $10.56 following Food and Drug Administration (FDA) approval on Wednesday for Horizant, an extended-release tablet for the treatment of Restless Legs Syndrome. Horizant is converted into gabapentin once it is absorbed in the body...